Navigation Links
MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
Date:10/16/2008

ment capabilities," Osbourn added.

The new facility is being inaugurated today with the unveiling of a commemorative plaque by honoured guest, Sir Aaron Klug.

The Aaron Klug Building forms part of MedImmune's wider expansion of its European operations. Its opening follows the recent refurbishment and expansion of one of the company's major production sites in Nijmegen in the Netherlands, where products such as Synagis(R) (palivizumab) and Ethyol(R) (amifostine) are prepared for distribution. Completed in early 2008, the newly refurbished site is capable of producing up to 10 discrete products each year, equating to 6.5 million vials.

About MedImmune

MedImmune is a leading innovation-focused biotechnology company whose mission it is to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on infection, oncology, respiratory disease and inflammation, cardiovascular/ gastrointestinal disease and neuroscience. Headquartered in Gaithersburg, Maryland, MedImmune has approximately 3,000 employees worldwide and is the wholly owned biologics business for AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
2. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
3. MedImmunes Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
4. Depth of MedImmunes Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society
5. MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
6. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
7. Seneca Valley High School Student Receives Science Award From MedImmune
8. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
9. MedImmune Submits Biologics License Application to FDA for Motavizumab
10. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
11. MedImmune Announces Seven Key Promotions and New Hires

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...wswire/--BlueMarbleEnergyCorp.announcedtodaythatth...A)wererecentlyawarded$2millionbyWashingtonState,sC...e/publicpartnershiptoconstructthestate,sfirstspeci..., "Thisinvestmentwillsignificantlyspeedthedevelopm...nCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wear...
(Date:11/24/2009)...9/PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc....eduledtopresentatthePiperJaffray21stAnnualHealthCa...(8:30a.m.PacificTime)attheNewYorkPalaceHotelinNewY...veOfficer,isscheduledtoprovideanoverviewofthecompa...rams. ,, Aliveaudiowebcastofthepresentationwill...
(Date:11/24/2009)...wswire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasd...PiperJaffrayHealthCareConference.Theconferencewill..., CTIwillpresentonTuesday,December1at11:00a.m.Ea...I,spresentationwillbeavailableat www.celltherapeut...ds. , ,PiperJaffrayHealthCareConference,NewYorkPa...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/--PDLBioPharma,Inc.(P...lishedNovember27,2009astheex-dividenddateforits$20...thesecuritizationtransactioncompletedonNovember2,2...ckholdersofrecordontherecorddate,December1,2009.NA...dat$1.67pershareofcommonstockforpurposesoftheex-di...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
... Austria, November 28 f-star, an antibody,enginee...ody fragments,based on its unique Modular Antibody...R 3.0 million from Novo A/S in a Second Closing of...y Aescap Venture and Atlas Venture.,After this Sec...nd,increases to EUR 9.0 million. In total, the Com...
... from animal model testing demonstrate ANAVEX 1-41... anti-amnesic benefits, GENEVA, Nov. 28 /PRNewswi...X") (OTCBB: AVXL) is pleased to announce promising... drug candidate for Alzheimer,s disease. In,recent...d oxidative stress,which damages and destroys cell...
... France, November 28 The results of a,study on ch...asses,sublingual desensitisation product, which is...y., The phase III paediatric study, VO52.06, whic...untries suffering from allergic,rhino-conjunctivit...onstrating a statistically significant reduction i...
Other Biology Technology:Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 2Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 3Anavex advances drug candidate for treatment of Alzheimer's disease 2Anavex advances drug candidate for treatment of Alzheimer's disease 3Anavex advances drug candidate for treatment of Alzheimer's disease 4Anavex advances drug candidate for treatment of Alzheimer's disease 5STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study 2
(Date:11/24/2009)...standing how sounds associated with Navy sonar mig...ey hear it at all. , The same type of large indu...ct flaws in the space shuttle,s behemoth solid fue...e the giant head of a whale. The scans are providi...s hearing anatomy using a breakthrough method deve...
(Date:11/24/2009)... Toxicology (ACMT) have signed an agreement to col...ical Toxicology (JMT), the official journal of th...y published by the University of Pennsylvania Pres...ternational, peer-reviewed journal, is dedicated t...xicology. The quarterly journal focuses on the di...
(Date:11/24/2009)...arch on bacterial communities throughout six large...ral patterns, suggesting that scientists could use...te change in the polar regions. The study, publish...cademy of Sciences Early Edition, shows that bact...onously over time, correlating with seasonal shift...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Nick Jonas 3A Livin the Dream Despite Diabetes 55255 1Nick Jonas 3A Livin the Dream Despite Diabetes 55255 2Nick Jonas 3A Livin the Dream Despite Diabetes 55255 3Nick Jonas 3A Livin the Dream Despite Diabetes 55255 4Naked 28R 29 Juice Brings Power to the People With Two New Protein Zone Flavors 3A Mango and Double Berry 55251 1Naked 28R 29 Juice Brings Power to the People With Two New Protein Zone Flavors 3A Mango and Double Berry 55251 2Jani King Recognized as Best in Support by the International Business Awards 55247 1Jani King Recognized as Best in Support by the International Business Awards 55247 2
...meaning to watching out for other mothers, kids. ...deer conducted by the University of Alberta in Edm...so in Canada, showed that both species responded t... the responses elicited when coyotes attack fawns,...il and mule deer calls, even when their own fawn s...
...rom the National Institutes of Health (NIH), resea...eveloping a physics-based virtual model that can s...sed in conjunction with existing 3-D models, addin... improve the accuracy and effectiveness of radiati...orge Xu, professor of nuclear and biomedical engin...
...h hungry bats, good-tasting moths increase their c...r bad-tasting cousins, according to a new Wake For...sue of the Proceedings of the National Academy of ...how how an animal species uses acoustic mimicry as...cted by Jesse Barber, a doctoral student in biolog...
Other Biology News:Mule deer moms rescue other fawns 2'Virtual Patient' to simulate real-time organ motions for radiation therapy 2Moths mimic sounds to survive 2
... 2, Monoclonal Antibody, Unconjugated Applicati...ICC: Use at an assay dependent dilution. WB: Use a...ion is determined using a whole extract of rat bra... in other applications. Optimal dilutions/concent...
Mouse Anti-G alpha o Monoclonal Antibody, Unconjugated, Clone 1C.2 from Sigma-Aldrich
Anti-SHP-2 Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Human PPAR gamma 2 Monoclonal Antibody, Unconjugated, Clone K8450B from Cosmo Bio Co., Ltd.
Biology Products: